Tapewire

NYSE · USD

LLY

ELI LILLY & Co

Export transactions ↓
Tapewire entity
2794
SEC CIK
0000059478
Parsed reports
2,757

Last 12 months

Inside the activity.

0 purchase rows · 240 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 20250200
Dec 202503
Jan 2026031
Feb 202600
Mar 202600
Apr 202600
May 202602
Jun 202601
Jul 202600
Aug 202603
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 03, 2025 Filed Nov 4, 2025 21:00 UTC SaleCommon Stock 21,884 $885.56 $19,379,529.39
Disclosure

SEC source: 0000316011-25-000049 · form4-11042025_041101.xml · nonDerivative · entry 9

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,100,989

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $885.145 to $886.14, inclusive.

Read SEC document
November 03, 2025 Filed Nov 4, 2025 21:00 UTC SaleCommon Stock 26,340 $884.67 $23,302,076.10
Disclosure

SEC source: 0000316011-25-000049 · form4-11042025_041101.xml · nonDerivative · entry 8

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,122,873

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $884.145 to $885.14, inclusive.

Read SEC document
November 03, 2025 Filed Nov 4, 2025 21:00 UTC SaleCommon Stock 10,681 $883.75 $9,439,291.03
Disclosure

SEC source: 0000316011-25-000049 · form4-11042025_041101.xml · nonDerivative · entry 7

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,149,213

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $883.14 to $884.12, inclusive.

Read SEC document
November 03, 2025 Filed Nov 4, 2025 21:00 UTC SaleCommon Stock 4,226 $882.32 $3,728,684.32
Disclosure

SEC source: 0000316011-25-000049 · form4-11042025_041101.xml · nonDerivative · entry 6

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,159,894

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $882.00 to $882.99, inclusive.

Read SEC document
November 03, 2025 Filed Nov 4, 2025 21:00 UTC SaleCommon Stock 6,373 $881.46 $5,617,550.95
Disclosure

SEC source: 0000316011-25-000049 · form4-11042025_041101.xml · nonDerivative · entry 5

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,164,120

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $881.00 to $881.98, inclusive.

Read SEC document
November 03, 2025 Filed Nov 4, 2025 21:00 UTC SaleCommon Stock 10,549 $880.45 $9,287,856.50
Disclosure

SEC source: 0000316011-25-000049 · form4-11042025_041101.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,170,493

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $880.00 to $880.99, inclusive.

Read SEC document
November 03, 2025 Filed Nov 4, 2025 21:00 UTC SaleCommon Stock 6,125 $879.36 $5,386,080.00
Disclosure

SEC source: 0000316011-25-000049 · form4-11042025_041101.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,181,042

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $879.00 to $879.80, inclusive.

Read SEC document
November 03, 2025 Filed Nov 4, 2025 21:00 UTC SaleCommon Stock 18,815 $878.36 $16,526,268.14
Disclosure

SEC source: 0000316011-25-000049 · form4-11042025_041101.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,187,167

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $878.00 to $878.99, inclusive.

Read SEC document
November 03, 2025 Filed Nov 4, 2025 21:00 UTC SaleCommon Stock 25,996 $877.40 $22,808,890.40
Disclosure

SEC source: 0000316011-25-000049 · form4-11042025_041101.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,205,982

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $877.00 to $877.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18), (19), (20), (21), (22), (23), and (24) to this Form 4.

Read SEC document
October 31, 2025 Filed Nov 3, 2025 21:00 UTC SaleCommon Stock 2,910 $869.47 $2,530,146.06
Disclosure

SEC source: 0000316011-25-000045 · form4-11032025_041101.xml · nonDerivative · entry 8

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,231,978

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $869.0023 to $869.9057, inclusive.

Read SEC document
October 31, 2025 Filed Nov 3, 2025 21:00 UTC SaleCommon Stock 5,440 $868.44 $4,724,324.48
Disclosure

SEC source: 0000316011-25-000045 · form4-11032025_041101.xml · nonDerivative · entry 7

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,234,888

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $868.00 to $868.9994, inclusive.

Read SEC document
October 31, 2025 Filed Nov 3, 2025 21:00 UTC SaleCommon Stock 4,602 $867.54 $3,992,437.49
Disclosure

SEC source: 0000316011-25-000045 · form4-11032025_041101.xml · nonDerivative · entry 6

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,240,328

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $867.00 to $867.9983, inclusive.

Read SEC document
October 31, 2025 Filed Nov 3, 2025 21:00 UTC SaleCommon Stock 10,358 $866.55 $8,975,693.83
Disclosure

SEC source: 0000316011-25-000045 · form4-11032025_041101.xml · nonDerivative · entry 5

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,244,930

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $866.00 to $866.997, inclusive.

Read SEC document
October 31, 2025 Filed Nov 3, 2025 21:00 UTC SaleCommon Stock 10,356 $865.60 $8,964,112.18
Disclosure

SEC source: 0000316011-25-000045 · form4-11032025_041101.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,255,288

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $865.00 to $865.99, inclusive.

Read SEC document
October 31, 2025 Filed Nov 3, 2025 21:00 UTC SaleCommon Stock 15,671 $864.53 $13,548,018.29
Disclosure

SEC source: 0000316011-25-000045 · form4-11032025_041101.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,265,644

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $864.00 to $864.9985, inclusive.

Read SEC document
October 31, 2025 Filed Nov 3, 2025 21:00 UTC SaleCommon Stock 54,191 $863.42 $46,789,809.98
Disclosure

SEC source: 0000316011-25-000045 · form4-11032025_041101.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,281,315

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $863.00 to $863.9999, inclusive.

Read SEC document
October 31, 2025 Filed Nov 3, 2025 21:00 UTC SaleCommon Stock 197,814 $862.63 $170,640,488.63
Disclosure

SEC source: 0000316011-25-000045 · form4-11032025_041101.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,335,506

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $862.00 to $862.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), and (8) to this Form 4.

Read SEC document
October 20, 2025 Filed Oct 22, 2025 20:19 UTC GrantCommon Stock 12.259 $808.96 $9,917.04
Disclosure

SEC source: 0000059478-25-000245 · wk-form4_1761164359.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,763.656

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
October 20, 2025 Filed Oct 22, 2025 20:24 UTC GrantCommon Stock 18.336 $808.96 $14,833.09
Disclosure

SEC source: 0000059478-25-000247 · wk-form4_1761164643.xml · nonDerivative · entry 1

LUCIANO JUAN R · CIK 0001455792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,474.296

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
October 20, 2025 Filed Oct 22, 2025 20:24 UTC GrantCommon Stock 6.129 $808.96 $4,958.12
Disclosure

SEC source: 0001262388-25-000006 · wk-form4_1761164695.xml · nonDerivative · entry 1

Sulzberger Gabrielle · CIK 0001262388 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,728.14

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
October 20, 2025 Filed Oct 22, 2025 20:17 UTC GrantCommon Stock 14.525 $808.96 $11,750.14
Disclosure

SEC source: 0001310215-25-000008 · wk-form4_1761164262.xml · nonDerivative · entry 1

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,151.946

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
October 20, 2025 Filed Oct 22, 2025 20:22 UTC GrantCommon Stock 12.259 $808.96 $9,917.04
Disclosure

SEC source: 0001340823-25-000008 · wk-form4_1761164553.xml · nonDerivative · entry 1

Hedley Mary Lynne · CIK 0001340823 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,015.828

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
October 10, 2025 Filed Oct 14, 2025 20:00 UTC SaleCommon Stock 3,190 $863.37 $2,754,147.11
Disclosure

SEC source: 0000316011-25-000037 · form4-10142025_041001.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,533,320

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $863.00 to $863.995, inclusive.

Read SEC document
October 10, 2025 Filed Oct 14, 2025 20:00 UTC SaleCommon Stock 468 $862.34 $403,575.12
Disclosure

SEC source: 0000316011-25-000037 · form4-10142025_041001.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,536,510

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $862.00 to $862.74, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.

Read SEC document
October 09, 2025 Filed Oct 10, 2025 20:00 UTC SaleCommon Stock 200 $857.26 $171,451.00
Disclosure

SEC source: 0000316011-25-000035 · form4-10102025_041001.xml · nonDerivative · entry 8

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,536,978

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $857.25 to $857.26, inclusive.

Read SEC document
October 09, 2025 Filed Oct 10, 2025 20:00 UTC SaleCommon Stock 835 $854.96 $713,888.26
Disclosure

SEC source: 0000316011-25-000035 · form4-10102025_041001.xml · nonDerivative · entry 7

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,537,178

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $854.91 to $855.09, inclusive.

Read SEC document
October 09, 2025 Filed Oct 10, 2025 20:00 UTC SaleCommon Stock 1,473 $854.61 $1,258,833.17
Disclosure

SEC source: 0000316011-25-000035 · form4-10102025_041001.xml · nonDerivative · entry 6

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,538,013

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $853.90 to $854.8575, inclusive.

Read SEC document
October 09, 2025 Filed Oct 10, 2025 20:00 UTC SaleCommon Stock 1,247 $853.20 $1,063,936.66
Disclosure

SEC source: 0000316011-25-000035 · form4-10102025_041001.xml · nonDerivative · entry 5

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,539,486

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $852.895 to $853.85, inclusive.

Read SEC document
October 09, 2025 Filed Oct 10, 2025 20:00 UTC SaleCommon Stock 2,472 $852.21 $2,106,655.70
Disclosure

SEC source: 0000316011-25-000035 · form4-10102025_041001.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,540,733

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $851.82 to $852.78, inclusive.

Read SEC document
October 09, 2025 Filed Oct 10, 2025 20:00 UTC SaleCommon Stock 3,375 $851.58 $2,874,092.63
Disclosure

SEC source: 0000316011-25-000035 · form4-10102025_041001.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,543,205

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $850.78 to $851.74, inclusive.

Read SEC document
October 09, 2025 Filed Oct 10, 2025 20:00 UTC SaleCommon Stock 400 $850.05 $340,020.00
Disclosure

SEC source: 0000316011-25-000035 · form4-10102025_041001.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,546,580

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $849.78 to $850.41, inclusive.

Read SEC document
October 09, 2025 Filed Oct 10, 2025 20:00 UTC SaleCommon Stock 600 $848.63 $509,178.00
Disclosure

SEC source: 0000316011-25-000035 · form4-10102025_041001.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,546,980

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $848.09 to $849.00, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), and (8) to this Form 4.

Read SEC document
October 08, 2025 Filed Oct 9, 2025 20:00 UTC SaleCommon Stock 200 $856.00 $171,200.00
Disclosure

SEC source: 0000316011-25-000031 · form4-10092025_041002.xml · nonDerivative · entry 8

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,547,580

Read SEC document
October 08, 2025 Filed Oct 9, 2025 20:00 UTC SaleCommon Stock 946 $854.64 $808,488.49
Disclosure

SEC source: 0000316011-25-000031 · form4-10092025_041002.xml · nonDerivative · entry 7

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,547,780

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $854.42 to $855.25, inclusive.

Read SEC document
October 08, 2025 Filed Oct 9, 2025 20:00 UTC SaleCommon Stock 3,881 $853.85 $3,313,776.33
Disclosure

SEC source: 0000316011-25-000031 · form4-10092025_041002.xml · nonDerivative · entry 6

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,548,726

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $853.25 to $854.21, inclusive.

Read SEC document
October 08, 2025 Filed Oct 9, 2025 20:00 UTC SaleCommon Stock 3,227 $852.36 $2,750,568.95
Disclosure

SEC source: 0000316011-25-000031 · form4-10092025_041002.xml · nonDerivative · entry 5

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,552,607

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $852.05 to $853.01, inclusive.

Read SEC document
October 08, 2025 Filed Oct 9, 2025 20:00 UTC SaleCommon Stock 13,624 $851.40 $11,599,514.47
Disclosure

SEC source: 0000316011-25-000031 · form4-10092025_041002.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,555,834

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $851.00 to $851.98, inclusive.

Read SEC document
October 08, 2025 Filed Oct 9, 2025 20:00 UTC SaleCommon Stock 36,114 $850.52 $30,715,643.17
Disclosure

SEC source: 0000316011-25-000031 · form4-10092025_041002.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,569,458

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $850.00 to $850.99, inclusive.

Read SEC document
October 08, 2025 Filed Oct 9, 2025 20:00 UTC SaleCommon Stock 25,296 $849.60 $21,491,405.71
Disclosure

SEC source: 0000316011-25-000031 · form4-10092025_041002.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,605,572

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $849.00 to $849.99, inclusive.

Read SEC document
October 08, 2025 Filed Oct 9, 2025 20:00 UTC SaleCommon Stock 18,132 $848.46 $15,384,276.72
Disclosure

SEC source: 0000316011-25-000031 · form4-10092025_041002.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,630,868

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $848.00 to $848.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), and (7) to this Form 4.

Read SEC document
October 07, 2025 Filed Oct 8, 2025 20:00 UTC SaleCommon Stock 26,795 $848.01 $22,722,401.16
Disclosure

SEC source: 0000316011-25-000029 · form4-10082025_041001.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,649,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $848.00 to $848.32, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
October 06, 2025 Filed Oct 7, 2025 20:00 UTC SaleCommon Stock 2,399 $855.71 $2,052,850.69
Disclosure

SEC source: 0000316011-25-000027 · form4-10072025_041001.xml · nonDerivative · entry 8

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,675,795

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $855.50 to $856.375, inclusive.

Read SEC document
October 06, 2025 Filed Oct 7, 2025 20:00 UTC SaleCommon Stock 7,143 $854.54 $6,104,000.65
Disclosure

SEC source: 0000316011-25-000027 · form4-10072025_041001.xml · nonDerivative · entry 7

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,678,194

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $854.22 to $855.00, inclusive.

Read SEC document
October 06, 2025 Filed Oct 7, 2025 20:00 UTC SaleCommon Stock 14,822 $853.65 $12,652,726.19
Disclosure

SEC source: 0000316011-25-000027 · form4-10072025_041001.xml · nonDerivative · entry 6

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,685,337

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $853.17 to $854.13, inclusive.

Read SEC document
October 06, 2025 Filed Oct 7, 2025 20:00 UTC SaleCommon Stock 9,767 $852.67 $8,328,057.19
Disclosure

SEC source: 0000316011-25-000027 · form4-10072025_041001.xml · nonDerivative · entry 5

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,700,159

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $852.14 to $853.13, inclusive.

Read SEC document
October 06, 2025 Filed Oct 7, 2025 20:00 UTC SaleCommon Stock 12,180 $851.58 $10,372,268.76
Disclosure

SEC source: 0000316011-25-000027 · form4-10072025_041001.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,709,926

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $851.055 to $852.035, inclusive.

Read SEC document
October 06, 2025 Filed Oct 7, 2025 20:00 UTC SaleCommon Stock 22,960 $850.65 $19,530,855.12
Disclosure

SEC source: 0000316011-25-000027 · form4-10072025_041001.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,722,106

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $850.055 to $851.01, inclusive.

Read SEC document
October 06, 2025 Filed Oct 7, 2025 20:00 UTC SaleCommon Stock 28,063 $849.44 $23,837,918.91
Disclosure

SEC source: 0000316011-25-000027 · form4-10072025_041001.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,745,066

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $849.005 to $850.00, inclusive.

Read SEC document
October 06, 2025 Filed Oct 7, 2025 20:00 UTC SaleCommon Stock 63,849 $848.30 $54,162,979.00
Disclosure

SEC source: 0000316011-25-000027 · form4-10072025_041001.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,773,129

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $848.00 to $848.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), and (8) to this Form 4.

Read SEC document
October 03, 2025 Filed Oct 6, 2025 20:00 UTC SaleCommon Stock 405 $847.60 $343,278.41
Disclosure

SEC source: 0000316011-25-000025 · form4-10062025_041001.xml · nonDerivative · entry 25

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,836,978

F24 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $847.49 to $847.63, inclusive.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.